Scuteri, D.; Rombolà , L.; Crudo, M.; Watanabe, C.; Mizoguchi, H.; Sakurada, S.; Hamamura, K.; Sakurada, T.; Tonin, P.; Corasaniti, M.T.;
et al. Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy. Pharmaceutics 2022, 14, 312.
https://doi.org/10.3390/pharmaceutics14020312
AMA Style
Scuteri D, Rombolà L, Crudo M, Watanabe C, Mizoguchi H, Sakurada S, Hamamura K, Sakurada T, Tonin P, Corasaniti MT,
et al. Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy. Pharmaceutics. 2022; 14(2):312.
https://doi.org/10.3390/pharmaceutics14020312
Chicago/Turabian Style
Scuteri, Damiana, Laura Rombolà , Michele Crudo, Chizuko Watanabe, Hirokazu Mizoguchi, Shinobu Sakurada, Kengo Hamamura, Tsukasa Sakurada, Paolo Tonin, Maria Tiziana Corasaniti,
and et al. 2022. "Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy" Pharmaceutics 14, no. 2: 312.
https://doi.org/10.3390/pharmaceutics14020312
APA Style
Scuteri, D., Rombolà , L., Crudo, M., Watanabe, C., Mizoguchi, H., Sakurada, S., Hamamura, K., Sakurada, T., Tonin, P., Corasaniti, M. T., & Bagetta, G.
(2022). Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy. Pharmaceutics, 14(2), 312.
https://doi.org/10.3390/pharmaceutics14020312
